Overview
Letrozole is a widely used active pharmaceutical ingredient (API) in the Oncology / Aromatase Inhibitor therapeutic category. It is supplied as a bulk pharmaceutical-grade material manufactured to meet stringent international quality standards.
Therapeutic Application
Letrozole is a non-steroidal aromatase inhibitor used in the adjuvant and extended adjuvant treatment of postmenopausal women with hormone-receptor-positive early breast cancer.
Specifications
- CAS Number: 112809-51-5
- Appearance: White to off-white crystalline powder
- Typical Assay/Purity: ≥ 99.0%
- Common Pharmacopeial Grades: USP, EP, BP, IP
- Storage: Store in a cool, dry place, away from light
- Shelf Life: Typically 24 months under recommended storage conditions
Regulatory & Compliance
Pharmint Exports adheres to WHO-GMP manufacturing practices, ensuring that Letrozole is produced in compliance with international quality standards. Availability of regulatory documents such as USDMF, CEP, and EU-GMP certificates, along with Certificates of Analysis (COA) and Certificates of Suitability (COS), is subject to inquiry.
Packaging & Shipping
Letrozole is packaged in 25kg HDPE drums with double LDPE liners, palletized for secure transport. All necessary export documentation is provided, facilitating shipping to key markets including USA, EU, Canada, Australia.
Common Use Cases & Finished Dosage Forms
This API is typically incorporated into various dosage forms including:
- Tablets
- Capsules
- Injectable solutions
Ordering Information
The minimum order quantity (MOQ) for Letrozole is subject to inquiry. Interested parties are encouraged to request a Certificate of Analysis (COA) and a quote via this listing. For further inquiries, please contact Pharmint Exports directly.
عمليات الاستعراض
There are no reviews yet.